BOULDER, Colo., April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a leading muscle disease biopharmaceutical company, today announced the pricing of an underwritten offering of 9,935,419 shares of its common stock at an offering price of $20.13 per share. Edgewise...
Read More Details
Finally We wish PressBee provided you with enough information of ( Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock )
Also on site :